Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Selecting antiplatelet therapy at the time of percutaneous intervention for an acute coronary syndrome: weighing the benefits and risks of prasugrel versus clopidogrel.

Salisbury AC, Wang K, Cohen DJ, Li Y, Jones PG, Spertus JA.

Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):27-34. doi: 10.1161/CIRCOUTCOMES.112.965624. Epub 2012 Dec 4.

2.

Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel.

Martin MT, Spinler SA, Nutescu EA.

Clin Ther. 2011 Apr;33(4):425-42. doi: 10.1016/j.clinthera.2011.04.007. Review.

PMID:
21635989
3.
4.

Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.

Tcheng JE, Mackay SM.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):83-91. doi: 10.2165/11594600-000000000-00000. Review.

PMID:
22316323
5.

Critical review of prasugrel for formulary decision makers.

Schafer JA, Kjesbo NK, Gleason PP.

J Manag Care Pharm. 2009 May;15(4):335-43. Review.

6.

Review of prasugrel for the secondary prevention of atherothrombosis.

Spinler SA, Rees C.

J Manag Care Pharm. 2009 Jun;15(5):383-95. Review.

7.

Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.

Baker WL, White CM.

Am J Cardiovasc Drugs. 2009;9(4):213-29. doi: 10.2165/1131209-000000000-00000. Review.

PMID:
19655817
8.

Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.

Thomas D, Giugliano RP.

Crit Pathw Cardiol. 2009 Mar;8(1):12-9. doi: 10.1097/HPC.0b013e318196bb46. Review.

PMID:
19258833
9.

Thienopyridine antiplatelet agents: focus on prasugrel.

Freeman MK.

Consult Pharm. 2010 Apr;25(4):241-57. doi: 10.4140/TCP.n.2010.241. Review.

PMID:
20511177
10.

Prasugrel for the treatment of patients with acute coronary syndrome.

Marzot F, Pengo V.

Vasc Health Risk Manag. 2009;5(1):321-4. Epub 2009 Apr 8. Review.

11.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
12.
13.

Prasugrel: a new antiplatelet drug for the prevention and treatment of cardiovascular disease.

Koo MH, Nawarskas JJ, Frishman WH.

Cardiol Rev. 2008 Nov-Dec;16(6):314-8. doi: 10.1097/CRD.0b013e318189a701. Review.

PMID:
18923235
14.

Prasugrel: a critical comparison with clopidogrel.

Reinhart KM, White CM, Baker WL.

Pharmacotherapy. 2009 Dec;29(12):1441-51. doi: 10.1592/phco.29.12.1441. Review.

PMID:
19947804
15.

Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Aradi D, Kom├│csi A, Vorobcsuk A, Serebruany VL.

Thromb Haemost. 2013 Jan;109(1):93-101. doi: 10.1160/TH12-06-0377. Epub 2012 Nov 29. Review.

PMID:
23197191
16.

[Extent of platelet aggregation inhibition and clinical events: new evidence with prasugrel].

Abbate R, Crea F, De Servi S, Filippi E, Gensini GF, Golinos P, Savonitto S.

G Ital Cardiol (Rome). 2010 Feb;11(2):127-37. Review. Italian.

PMID:
20408476
17.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
18.

Prasugrel: Clinical development and therapeutic application.

Guerra DR, Tcheng JE.

Adv Ther. 2009 Nov;26(11):999-1011. doi: 10.1007/s12325-009-0081-y. Epub 2009 Dec 17. Review.

PMID:
20020231
19.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
20.

Acute coronary syndromes: identifying the appropriate patient for prasugrel.

Stephens JC, Askari AT.

Postgrad Med. 2012 Mar;124(2):16-28. doi: 10.3810/pgm.2012.03.2533. Review.

PMID:
22437212

Supplemental Content

Support Center